Medtronic
Medtronic
Medtronic
Medtronic Home | About Medtronic | Health Information | Information for patients | Information for physicians
   
   
   
Medtronic
Medtronic

Medtronic
Medtronic

Who can benefit from Intrathecal Drug Delivery?

IDD has proven efficacy in intractable nociceptive pain patients where other therapies have failed,
e.g. when oral analgesics have not been effective or cause intolerable side-effects

IDD with SynchroMed has been successfully used to treat:

  • FBS where pain is predominantly in the lower back, in multiple sites, or of a dominant nociceptive nature. Also for FBS in cases where neurostimulation was unsuccessful
  • CRPS with radicular pain and/or diffuse nociceptive pain and CRPS-associated dystonia. Also for CRPS in cases where neurostimulation was unsuccessful
  • Difficult cancer pain and visceral pain cases
Indications for Intrathecal Drug Delivery in areas
Nociceptive FBS Polyarthritis
Chronic regional pain syndromes Osteoporosis
Cancer pain Spinal stenosis
Visceral pain/pancreatitis Osteomyelitis
Spinal cord injury Coccygodynia
Osteoarthritis Myoclonic spasm
Dystonia  




back
 

top